Skip to main content
Premium Trial:

Request an Annual Quote

OSI Hires Transgenomic to Analyze Genetic Mutations for Cancer

NEW YORK (GenomeWeb News) — Transgenomic today said it will analyze cancer pathway genes for OSI Pharmaceuticals using a high-throughput methodology it developed for characterizing gene variants in malignant tumors.
 
Transgenomic said its high-throughput scanning offers forward and reverse Sanger sequencing and variant annotation to detect the mutations, and that it will be used to help OSI in its cancer drug-development programs.
 
Financial terms of the agreement were not disclosed.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.